Llwytho...
Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer’s and Parkinson’s Diseases
Accurate, reliable, and objective biomarkers for Alzheimer’s disease (AD), Parkinson’s disease (PD), and related age-associated neurodegenerative disorders are urgently needed to assist in both diagnosis, particularly at early stages, and monitoring of disease progression. Technological advancements...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Neurochem |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535381/ https://ncbi.nlm.nih.gov/pubmed/30474862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.14635 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|